Routy et al. demonstrated that Akkermansia muciniphila enhances the effectiveness of anti-PD-L1 and anti-PD-1 therapies by facilitating the recruitment of CCR9+CXCR3+CD4+ T lymphocytes to tumor sites [70]. This evidence concerns the gene CD274 and neoplasm.